![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Distinct evolutionary pathways of NS5A inhibitor resistance in patients with genotype 1a versus 1b infection during monotherapy with MK-8742 (Elbasvir)
|
|
|
Reported by Jules Levin
AASLD 2016 Nov 11-15 Boston, MA
Sara Williford, M.D., Shuntai Zhou, M.D., Christina Burch, Ph.D., Ernest Asante-Appiah, Ph.D., Anita Howe, Ph.D., Ronald Swanstrom, Ph.D., Stanley M. Lemon, M.D.
University of North Carolina at Chapel Hill Merck Research Laboratories
![HCV1](../images/111516/111516-8/HCV1.gif)
![HCV2](../images/111516/111516-8/HCV2.gif)
![HCV3](../images/111516/111516-8/HCV3.gif)
![HCV4](../images/111516/111516-8/HCV4.gif)
![HCV5](../images/111516/111516-8/HCV5.gif)
![HCV6](../images/111516/111516-8/HCV6.gif)
![HCV7](../images/111516/111516-8/HCV7.gif)
![HCV8](../images/111516/111516-8/HCV8.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|